TC Medical(SH:600763) Sou Hu Cai Jing·2026-02-07 00:39Core Viewpoint - Tongce Medical (600763) experienced a decline of 2.16% on February 6, 2026, closing at 49.72 yuan, with significant fluctuations in capital flow and financing activities [1][2]. Group 1: Stock Performance and Capital Flow - On February 6, 2026, the stock had a turnover rate of 3.12%, with a trading volume of 139,700 hands and a total transaction amount of 701 million yuan [1]. - The net outflow of main funds was 21.2 million yuan, accounting for 3.02% of the total transaction amount, while retail investors saw a net outflow of 201.46 thousand yuan, representing 0.29% [1]. - Over the past five days, the stock's performance showed fluctuations, with a peak increase of 4.05% on February 5, 2026, followed by a decline on February 6, 2026 [1][2]. Group 2: Financing and Margin Trading - On February 6, 2026, the financing buy amounted to 76.85 million yuan, while financing repayment was 58.29 million yuan, resulting in a net financing purchase of 18.56 million yuan [1]. - The margin trading balance stood at 792 million yuan, with a margin balance of 10.36 million yuan and a remaining short selling volume of 20,840 shares [1][2]. Group 3: Company Financials and Industry Comparison - As of the latest report, Tongce Medical's total market value is 22.239 billion yuan, with a net asset of 4.703 billion yuan and a net profit of 514 million yuan [4]. - The company has a price-to-earnings ratio of 32.48 and a price-to-book ratio of 5.12, with a gross margin of 41.69% and a net margin of 26.91% [4]. - In the first three quarters of 2025, the company's main revenue reached 2.29 billion yuan, reflecting a year-on-year increase of 2.56%, while the net profit increased by 3.16% to 514 million yuan [4].